MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...
Faith writes guides, how-tos, and roundups on the latest Android games and apps for Android Police. You'll find her writing about the newest free-to-play game to hit Android or discussing her paranoia ...
RIYADH, Saudi Arabia: Lifera, a PIF Company, announces the signing of a non-binding Memorandum of Understanding (MOU) with MSD (also known as Merck & Co., Inc., Rahway, N.J., USA in the U.S. and ...
Merck & Co (MSD) has broken ground on its new pharmaceutical manufacturing Centre of Excellence in Virginia, US, amid looming tariff threats from the Trump administration. The $3bn site, which is ...
Adam Piekarski decided to go it alone after more than a decade at BDT & MSD Partners. He’s backing up that bet with a historic unveiling. Derby Lane Partners has amassed $1.8 billion in commitments ...
ST. LOUIS – From a hospital to housing complexes, some of our area’s largest institutions are behind on their utility bills. Thousands of account holders owe more than $100 million owed to the ...
The dynamic, innovative, and agile environment that is the pharmaceutical industry requires a particular set of skills. For MSD Ireland, one of the country’s largest healthcare companies with eight ...
In his decades-long career in tech journalism, Dennis has written about nearly every type of hardware and software. He was a founding editor of Ziff Davis’ Computer Select in the 1990s, senior ...
Summit founder and president Quint Rubald, CEO Jeff Evrard and the broader management team will remain shareholders and continue to lead the company Founded in 1999, Summit has locations across 37 ...
MSD is slashing $3bn (€2.59bn) from its annual spending as it braces for off-brand competition to its Irish-manufactured cancer drug Keytruda, the best-selling medicine in the world. The drugmaker ...
Citing limited benefit and existing recordkeeping requirements, OSHA ends its rulemaking effort to add a musculoskeletal disorders column to the OSHA 300 Log. OSHA has officially withdrawn its ...